Extracorporeal removal of proinflammatory cytokines by specific adsorption onto microspheres

ASAIO Journal

Volumn 42, Issue 5, 1996, Pages

  Weber, C ^a,b   Falkenhagen, D ^a  

^a Donau Univ   (Austria)

^b DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADSORPTION; ANTIBODIES; ANTIGENS; BIOCOMPATIBILITY; BLOOD; CELLS; CELLULOSE; DISEASES; IRON OXIDES; PURIFICATION;

EXTRACORPOREAL BLOOD PURIFICATION; HUMAN PLASMAS; INTERLEUKIN; MICROSPHERE BASED DETOXIFICATION SYSTEM; PARAMAGNETIC MICROSPHERES; PROINFLAMMATORY CYTOKINES; SEPSIS; TUMOR NECROSIS FACTOR;

PATIENT TREATMENT;

CYTOKINE; ENDOTOXIN; INTERLEUKIN 1BETA; MICROSPHERE; POLYCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SORBENT; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; COVALENT BOND; DETOXIFICATION; HEMODIALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; SEPSIS;

EID: 0030250451     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199609000-00126     Document Type: Article

References (15)

1. Talan DA: Recent developments in our understanding of sepsis: Evaluation of anti-endotoxin antibodies and biological response modifiers. Ann Emerg Med 22: 1871-1890, 1993.
2. Wolff SM: Monoclonal antibodies and the treatment of Gramnegative bacteremia and shock. N Engl J Med 324: 486-488, 1991.
3. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock: Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169: 333-338, 1989.
4. Debets JMH, Kampmeijer R, van der Linden MPMH, Buurman WA, van der Linden CJ: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489-494, 1989.
5. Hack CE, De Groot ER, Felt-Bersma RJF, et al: Increased plasma levels of interleukin-6 in sepsis. Blood 74: 1704-1710, 1989.
6. Offner F, Philippé J, Vogelaers D, et al: Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 116: 100-105, 1990.
7. Calandra T, Baumgartner JD, Grau CE, et al: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferonalpha, and interferon-gamma in the serum of patients with septic shock. J Infect Dis 161: 982-987, 1990.
8. Sullivan JS, Kilpatrick L, Costarino AT, Lee Shao Chi, Harris MC: Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr 120: 510-515, 1992.
9. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann intern Med 119: 771-778, 1993.
10. Weber C, Rajnoch C, Loth F, Schima H, Falkenhagen D: The Microspheres based Detoxification System (MDS): A new extracorporeal blood purification technology based on recirculated microspherical adsorbent particles, Int J Artif Organs 17: 595-602, 1994.
11. Weber C, Henne B, Loth F, Schoenhofen M, Falkenhagen D: Development of cationically modified cellulose adsorbents for the removal of endotoxins. ASAIO J 41: M430-M434, 1995.
12. Nagaki M, Hughes RD, Lau JYN, Williams R: Removal of endotoxin and cytokines by adsorbents and the effect of plasma protein binding, Int J Artif Organs 14: 43-50, 1991.
13. Nagaki M, Hughes RD, Keane HM, Lau JYN, Williams R: In vitro plasma perfusion through adsorbents and plasma ultrafiltration to remove endotoxin and cytokines. Circ Shock 38:182-188, 1992.
14. Inthorn D, Hoffmann JN: Elimination of inflammatory mediators by hemofiltration. Int J Artif Organs 19: 124-126, 1996.
15. Stegmayr BG, Jakobson S, Rydvall A, Bjoersell-Oestling E: Plasma exchange in patients with acute renal failure in the course of multiorgan failure, Int J Artif Organs 18: 45-52, 1995.